Personal information

Websites & social links

BU Profiles
Boston Medical Center Physician Profile
Department of Medicine Faculty

Biography

My expertise in presentation of scientific data, bedside education, communication and negotiation, conflict resolution, curriculum development, leading teams and meetings, solving problems, researching and presenting medical literature, quality improvement, strategic planning, delivering health care and comprehending law and ethics results from 14 years as Director of the Medical Intensive Care Unit, 31 years as an academic physician dedicated to education, research and clinical care, 6 years participation in the Ethics Committee and production of over 200 opinions and testimony in personal injury and medical malpractice.

Activities

Collapse all

Works (20)

Correlation of Cough with Disease Activity and Treatment with Cyclosphosphamide in Scleroderma Interstitial Lung Disease: Findings from the Scleroderma Lung Study.

2011-12-08 | Standards or policy
DOI:

10.1378/chest.11-0801

PMID:

22156609
Source: Self-asserted source
Arthur Theodore

An unseen danger: frequency of posterior vessel wall penetration by needles during attempts to place internal jugular vein central catheters using ultrasound guidance.

2010-01-01 | Standards or policy
DOI:

10.1097/CCM.0b013e3181bfe76e

PMID:

20023505
Source: Self-asserted source
Arthur Theodore

Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease: lessons from clinical trials.

2009-04-01 | Standards or policy
DOI:

10.1007/s11926-009-0016-2

PMID:

19296883
Source: Self-asserted source
Arthur Theodore

Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay.

2008-02-01 | Standards or policy
DOI:

10.1097/01.CCM.0000300275.63811.B3

PMID:

18091554
Source: Self-asserted source
Arthur Theodore

Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease.

2007-09-27 | Standards or policy
DOI:

10.1164/rccm.200705-655OC

PMID:

17901414
Source: Self-asserted source
Arthur Theodore

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

2007-08-23 | Standards or policy
DOI:

10.1164/rccm.200702-326OC

PMID:

17717203
Source: Self-asserted source
Arthur Theodore

Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.

2007-05-01 | Standards or policy
DOI:

10.1002/art.22580

PMID:

17469162
Source: Self-asserted source
Arthur Theodore

Cyclophosphamide versus placebo in scleroderma lung disease.

2006-06-22 | Standards or policy
DOI:

10.1056/NEJMoa055120

PMID:

16790698
Source: Self-asserted source
Arthur Theodore

Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study.

2005-09-01 | Standards or policy
DOI:

10.1378/chest.128.3.1674

PMID:

16162774
Source: Self-asserted source
Arthur Theodore

Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.

2005-02-01 | Standards or policy
DOI:

10.1002/art.20787

PMID:

15692967
Source: Self-asserted source
Arthur Theodore

Measurement of interleukin 16.

2001-05-01 | Standards or policy
DOI:

10.1002/0471142735.im0623s22

PMID:

18432814
Source: Self-asserted source
Arthur Theodore

Cytokine binding to CD4+ inflammatory cells: implications for asthma.

1994-11-01 | Standards or policy
DOI:

10.1164/ajrccm/150.5_Pt_2.S59

PMID:

7952594
Source: Self-asserted source
Arthur Theodore

Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression.

1994-05-24 | Standards or policy
DOI:

10.1073/pnas.91.11.5109

PMID:

7910967
Source: Self-asserted source
Arthur Theodore

Mechanisms of lymphocyte accumulation in pulmonary disease.

1993-02-01 | Standards or policy
DOI:

10.1378/chest.103.2_Supplement.88S

PMID:

8094048
Source: Self-asserted source
Arthur Theodore

Lymphocyte chemoattractant factor induces CD4-dependent intracytoplasmic signaling in lymphocytes.

1991-05-01 | Standards or policy
DOI:

Not found

PMID:

1673145
Source: Self-asserted source
Arthur Theodore
grade
Preferred source (of 16)‎

Lymphocyte recruitment to the lung.

1990-07-01 | Standards or policy
DOI:

10.1164/ajrccm/142.1.238

PMID:

2195933
Source: Self-asserted source
Arthur Theodore

Lymphocyte motility and lymphocyte chemoattractant factors.

1988-11-01 | Standards or policy
DOI:

10.3109/08820138809089017

PMID:

3068125
Source: Self-asserted source
Arthur Theodore

A human T-T-cell hybridoma-derived lymphocyte chemoattractant factor.

1986-04-01 | Standards or policy
DOI:

10.1016/0008-8749(86)90300-X

PMID:

3093096
Source: Self-asserted source
Arthur Theodore

Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subset.

1985-10-01 | Standards or policy
DOI:

10.1016/0008-8749(85)90299-0

PMID:

3161625
Source: Self-asserted source
Arthur Theodore

Errant placement of nasoenteric tubes. A hazard in obtunded patients.

1984-12-01 | Standards or policy
DOI:

10.1378/chest.86.6.931

PMID:

6499559
Source: Self-asserted source
Arthur Theodore
How many people are using ORCID?